Latest News

Add to Favorites | Subscribe | Share

Filters:

  • (Press "esc" to clear)

Medicine

Channels:

Italian-American Researchers Present Mediterranean Diet, Health, and Longevity at Annual Medical Conference

Sbarro Health Research Organization President Antonio Giordano introduces program at National Italian American Foundation 42nd Anniversary Gala Weekend In Washington D.C.

Medicine

Channels:

Cell Cycle, retinoblastoma gene, Rb2/P130, Mesenchymal Stem Cell , Senescence, p107, Sbarro Health Research Organization, Antonio Giordano, temple univeristy, Mouse Model, Tumor Suppressor Gene, Longevity

Research Reveals Gene Differences in Mouse Model Versus Humans

Figure4Revised.jpg

Aspects of gene function in humans can be predicted by studies of the corresponding gene in mice, but new research findings have revealed important divergences between the species which scientists will need to understand better through further investigation.

Medicine

Channels:

Lung Cancer, Chemotherapy, Radiation Therapy, mPEBev

Adding Radiation Treatments to Inoperable Lung Cancer Increases Survival by up to One Year

SbarroRadiotherapy-ReleaseJune272017.jpg

Patients with unresectable, or inoperable, lung cancer are often given a dismal prognosis, with low rates of survival beyond a few years. Researchers exploring combination therapies have recently discovered improved survival rates by up to one year when patients treated with a newly formulated chemotherapy regimen are also given radiation therapy.

Medicine

Channels:

Cell Cycle, retinoblastoma gene, Alzheimer, Degenerative Disease, neuron death, Antonio Giordano, Sbarro Health Research Organization, temple univeristy, Tumor Suppressor Genes, Rb2/P130

Targeting Cell Cycle Reactivation Caused by Inflammation May Provide the Way to Prevent Neuron Death in Alzheimer’s Disease

confocalfuorescencemicroscopyofneurons.jpg

Researchers have discovered a clue to the mechanism for neuronal degeneration and possible target for a therapeutic approach to these disorders.

Medicine

Channels:

Cancer, Radiology, Nephrology, Kidney, Contrast-induced-nephropathy, CIN, Contrast Media, Iodine, iodated contrast media, Oncology, Patient Safety, Healthcare, Sbarro Health Research Organization

Does Radiology Contrast Medium Matter? To Fragile Cancer Patients, Yes

Given the choice of contrast medium for a computed tomography (CT) scan, most patients wouldn’t know the difference between the two iodine-based options commonly used in cancer cases. But for some patients, particularly in the already fragile and potentially compromised cancer patient, it is important to be aware that iodated contrast media has been linked to kidney impairment and a condition known as Contrast-induced nephropathy (CIN).

Medicine

Channels:

Breast Cancer

Clinical Data Confirms Efficacy of Pre-Surgery Chemo in Triple-Negative Breast Cancer

Researchers analyzed data confirming the improved outcomes in both short- and long-term survival in patients that underwent neoadjuvant chemotherapy prior to surgery for triple-negative breast cancer. The study included 213 patients at 8 Italian cancer centres whose diagnoses were characterized by clinical, molecular, and therapeutic features of triple-negative breast cancer, an aggressive form of cancer with limited treatment options.

Medicine

Channels:

glucose transporter 1, Ovarian Cancer, GLUT1, glucose transporter receptor

Unexpected Presence of Glucose Receptor in Ovarian Cancer Links Metabolism to Most Aggressive Cases

image10X.jpg

A new study of non-diabetic women with ovarian cancer reveals a potential correlation and area for further study regarding the expression of the GLUT1 glucose transporter receptor at the cancer tissue level. GLUT1 is a receptor protein involved in the absorption of glucose, or sugar, in the bloodstream and across membranes in the body.

Medicine

Channels:

Tomato Extract Fights Stomach Cancer, Ripe for Further Study

gastric-cancer-tomato-study3.jpg

A new study suggests that the use of tomato — a key food of the Mediterranean diet — should be explored to develop supportive strategies against gastric cancer

Medicine

Channels:

Smoking and cancer, Lung Cancer

Thorough Genotyping and Repurposed Drugs Key to Treating Small-Cell Lung Cancer, says Cancer Expert

Slide1.jpg

Cancer expert Antonio Giordano, MD, PhD, Director of the Sbarro Institute for Cancer Research and Molecular Medicine at Temple University, describes the recent progress and future possibilities of treating SCLC.

Medicine

Channels:

Sbarro Health Research Organization President Re-Elected to Board of Italian American Foundation

IMG_5106.JPG

Giordano is joined on the board by Corporation for Public Broadcasting President and CEO Patricia de Stacy Harrison and former Talk America President, Chairman and CEO Gabriel A. Battista who will serve as co-chairperson of the Foundation







Chat now!